Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Master Style PCLBKK:MASTER +1.13%54 3-Year EBITDA Growth Rate is 21.70% as of Mar. 2026, which is 46% below its 10-year median of 40.35. GuruFocus rates BKK:MASTER with a GF Score™ of 54/100 and a GF Value™ of ฿41.73 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Master Style PCL ranks better than 68.06% on this metric.
During the past 12 months, Master Style PCL's average EBITDA Per Share Growth Rate was -40.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 21.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Master Style PCL was 59.00% per year. The lowest was 21.70% per year. And the median was 40.35% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Master Style PCL 3-Year EBITDA Growth Rate Related Terms
BKK:MASTER vs HCA, THC, DVA: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Master Style PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Master Style PCL 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Master Style PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Master Style PCL's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 21.70% mean?
Master Style PCL (BKK:MASTER) has a 3-Year EBITDA Growth Rate of 21.70% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Master Style PCL and its competitors. This is 46% below median its historical median of 40.35. Over the past decade, Master Style PCL's 3-Year EBITDA Growth Rate has ranged from 21.70 to 59.00. According to the industry distribution chart, Master Style PCL ranks #168 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 31.9%.
Is Master Style PCL's 3-Year EBITDA Growth Rate too high?
Master Style PCL's current 3-Year EBITDA Growth Rate of 21.70% is 46% below median its 10-year median of 40.35. Over the past 10 years, this metric has ranged from a low of 21.70 to a high of 59.00. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Master Style PCL's value of 21.70% is 112.7% above this industry median. Based on the distribution chart, Master Style PCL ranks #168 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Master Style PCL has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Master Style PCL's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Master Style PCL ranks #168 out of 526 companies for 3-Year EBITDA Growth Rate. This puts Master Style PCL in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. Master Style PCL's value of 21.70% is 112.7% above this benchmark. Historically, Master Style PCL's own 3-Year EBITDA Growth Rate has ranged from 21.70 to 59.00 over the past decade. While the company's 10-year median is 40.35 vs. the industry median of 10.20, Master Style PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Master Style PCL's current 3-Year EBITDA Growth Rate of 21.70% is 112.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Master Style PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Master Style PCL's current 3-Year EBITDA Growth Rate is 21.70%, which is 46% below median its own 10-year median of 40.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Master Style PCL stock overvalued right now?
Based on GuruFocus' analysis, Master Style PCL (BKK:MASTER) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿41.73, compared to a current price of ฿8.85 — trading 78.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 21.70%, which is 46% below median its 10-year median of 40.35 and 112.7% above the Healthcare Providers & Services industry median of 10.20. Master Style PCL's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Master Style PCL (BKK:MASTER), the current 3-Year EBITDA Growth Rate is 21.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Master Style PCL (BKK:MASTER) Overvalued in 2026?
Based on GuruFocus' analysis, Master Style PCL stock appears to be undervalued.
The current stock price of ฿8.85 is trading 78.8% below its estimated GF Value™ of ฿41.73.
GuruFocus considers Master Style PCL to be Significantly Undervalued.
Key valuation signals for BKK:MASTER:
3-Year EBITDA Growth Rate: 21.70% (46% below median its 10-year median of 40.35)
GF Value™: ฿41.73 vs. price of ฿8.85 (78.8% below fair value)
Industry Position: 112.7% above the Healthcare Providers & Services median (#168 of 526)
No single metric tells the full story. See the BKK:MASTER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Master Style PCL is principally engaged in a cosmetic surgery hospital under the name of Masterpiece Hospital. It is a skincare and cosmetic surgery clinic. The company's services include: eye surgery, Nose surgery, Facial surgery, Hair transplant Liposuction and others. The company has two principal segments; Hospital business, which generates the majority of the revenue, and the trading of cosmetic products.
54GF Score
Get the complete analysis for BKK:MASTER
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MASTER has been successfully added to your 
